The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Yurkovskiy A.M.

Gomel State Medical University

Pankratov O.V.

Belarusian Medical Academy of Postgraduate Education

Paroshyna L.A.

Gomel State Medical University

Achinovich S.L.

Gomel State Medical University;
Gomel Regional Clinical Oncological Dispensary

Localized scleroderma: correlation of clinical, ultrasound, histological, and immunohistochemical data

Authors:

Yurkovskiy A.M., Pankratov O.V., Paroshyna L.A., Achinovich S.L.

More about the authors

Read: 1951 times


To cite this article:

Yurkovskiy AM, Pankratov OV, Paroshyna LA, Achinovich SL. Localized scleroderma: correlation of clinical, ultrasound, histological, and immunohistochemical data. Russian Journal of Clinical Dermatology and Venereology. 2022;21(4):565‑571. (In Russ.)
https://doi.org/10.17116/klinderma202221041565

Recommended articles:

References:

  1. Pankratov OV, Paroshyna LA. Ogranichennaja sklerodermija: jetiopatogenez, klinika, diagnostika, lechenie. Zdravoohranenie. 2019;6:28-38. (In Russ.).
  2. Bakalec NF, Paroshyna LA. Metabolic syndrome as a risk factor of skin pathology. Problemy zdorov’ya i ekologii. 2018;58(4):9-15. (In Russ.).
  3. Careta MF, Romiti R. Localized scleroderma: clinical spectrum and therapeutic update. Anais Brasileiros de Dermatologia. 2015;90(1):62-73.  https://doi.org/10.1590/abd1806-4841.20152890
  4. Lis-Święty A, Janicka I, Skrzypek-Salamon A, Brzezińska-Wcisło L. A systematic review of tools for determining activity of localized scleroderma in paediatric and adult patients. J Eur Acad Dermatol Venereol. 2017; 31(1):30-37.  https://doi.org/10.1111/jdv.13790
  5. Yurkovskij AM. Paroshyna LA, Achinovich SL. Diagnosticheskoe znachenie stepeni jekspressii biomarkerov Collagen IV, CD 34 i Vimentin u pacientov s ogranichennoj sklerodermiej. Zdravoohranenie. 2021;3:56-60. (In Russ.).
  6. Nouri S, Jacobe H. Recent developments in diagnosis and assessment of morphea. Curr Rheumatol Rep. 2013;15:308.  https://doi.org/10.1007/s11926-012-0308-9
  7. Nezafati KA, Cayce RL, Susa JS, et al. 14-MHz Ultrasonography as an outcome measure in morphea (localized scleroderma). Arch Dermatol. 2011; 147(9):1112-1115. https://doi.org/10.1001/archdermatol.2011.243
  8. Cosnes A, Anglade MC, Revuz J, Radier C. Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma. Br J Dermatol. 2003; 148(4):724-729.  https://doi.org/10.1046/j.1365-2133.2003.05289.x
  9. Li SC, Liebling MS, Haines KA. Ultrasonography is a sensitive tool for monitoring localized scleroderma. Rheumatology (Oxford). 2007;46(8):1316-1319. https://doi.org/10.1093/rheumatology/kem120
  10. Porta F, Kaloudi O, Garzitto A, Prignano F, Nacci F, Falcini F, Cerinic MM. High frequency ultrasound can detect improvement of lesions in juvenile localized scleroderma. Mod Rheumatol. 2014;24(5):869-873.  https://doi.org/10.3109/14397595.2013.844301
  11. Li SC, Liebling MS, Ramji FG, Opitz S, Mohanta A, Kornyat T, Zhang S et al. Sonographic evaluation of pediatric localized scleroderma: preliminary disease assessment measures. Pediatric Rheumatology. 2010;8:14.  https://www.ped-rheum.com/content/8/1/14
  12. Li SC, Liebling MS. The use of Doppler ultrasound to evaluate lesions of localized scleroderma. Curr Rheumatol Rep. 2009;11(3):205-211.  https://doi.org/10.1007/s11926-009-0028-y

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.